Skip to main content

Erik Christensen, Anders Lönneborg, Albert Luderer

Premium
Erik Christensen has been named managing director of DiaGenic effective Jan 1, 2007, the Norwegian diagnostics firm said this week.
 
Christensen currently manages the diagnostics division of Abbott Norway. DiaGenic’s current managing director and co-founder Anders Lönneborg will now serve as scientific director.
 

 
BioTrove has appointed Albert Luderer president and CEO.
 
Luderer, who will also become a BioTrove director, comes to the company from Light Sciences, where he was also president and CEO.
 
He has also been president and chief operating officer of BioMérieux and has held senior positions at Dianon Systems and Boehringer Mannheim.
 
Luderer has a BA from Drew University and an MS and PhD from Rutgers University.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.